A study of serum Cystatin C levels in type 2 diabetes mellitus patients with normoalbuminuria, microalbuminuria and macroalbuminuria

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 7, Issue 2

Abstract

Background: Diabetic nephropathy, a major microvascular complication of diabetes mellitus, is a leading cause of end-stage renal disease. Early detection of renal dysfunction is the only way to avoid the morbidity and mortality in type 2 diabetes mellitus(T2DM). Many studies have demonstrated that serum cystatin C is an accurate and sensitive marker for detecting early renal impairment in T2DM. Hence this study was done to assess the serum cystatin C as an early marker of diabetic nephropathy. Aim: To measure the serum cystatin C levels in T2DM patients with normoalbuminuria, microalbuminuria and macroalbuminuria. Materials and Methods: 90 known T2DM patients in the age group of 40-70 years were selected and further categorized according to the urine albumin-creatinine ratio into normoalbuminuria, microalbuminuria and macroalbuminuria, with 30 patients in each group. Height, weight, BMI and serum cystatin C were measured. Results: Mean of cystatin C was 0.94+0.23, 1.11+0.25 and 1.64+0.68 mg/L for the three groups respectively. In group A, group B and group C, the normal cystatin C levels were 70%, 56.7% and 20% respectively. Conclusion: Cystatin C is more sensitive, possibly a better marker for detection of early renal impairment in T2DM.

Authors and Affiliations

Sindu Priya S, Uma Maheswari S

Keywords

Related Articles

Association of serum leptin and diastolic blood pressure in pre-eclamptic women

Background: Maternal peripheral leptin levels are enhanced during normal pregnancy and collectively suggest that leptin concentrations peak in the second trimester. A better understanding of leptin and its role in PE may...

Study on correlation between high density lipoprotein and cardiac markers in patients of type II diabetes mellitus complicated with hypertension

Problem statement: Diabetes mellitus is characterized by loss of the insulin-producing beta cells of the isolates of Langerhans is the pancreas, leading to insulin deficiency. In the early stage of type 2, the predominan...

Correlation of serum malondialdehyde level with components of metabolic syndrome

Background: Metabolic syndrome is one of the major public health concerns and is emerging as a pandemic. oxidative stress is a hallmark of metabolic syndrome and plays a central role in the progression of the disease. Ma...

Utility of serum HE4 level to diagnose epithelial ovarian cancer - A cross sectional study

Background: Epithelial Ovarian cancer is most common and lethal gynecological malignancy. Diagnosis of ovarian cancer at early stage remains in challenge because of unavailability of accurate tumor marker that detects ca...

Evaluation of thyroid function in patients of chronic kidney disease

Background: Chronic Kidney Disease (CKD) is abnormal kidney function with low GFR (<60 ml/min/1.73m2) for 3 or more months. Prevalence of CKD in India is 17.2% and over 2 million people world wide receive dialysis treatm...

Download PDF file
  • EP ID EP442188
  • DOI 10.26611/1002722
  • Views 184
  • Downloads 0

How To Cite

Sindu Priya S, Uma Maheswari S (2018). A study of serum Cystatin C levels in type 2 diabetes mellitus patients with normoalbuminuria, microalbuminuria and macroalbuminuria. Medpulse International Journal of Biochemistry, 7(2), 17-20. https://europub.co.uk/articles/-A-442188